Shields Matthew
- SEC CIK
- 0002025621
In the past year, 3 open-market sale filings worth $1.40M and no purchases.
Current role at each company
- TEVA Teva Pharmaceutical Industries LtdEVP, Global Operationsas of Jun 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.40M
- 3 filings
- Net
- −$1.40M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Shields Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Shields MatthewEVP, Global Operations | SSale | −9.99K | $32.19 | −$321.5K | −100.0%0 after | |
| Jun 4, 2026 (view filing) | Jun 3 | 1 day | Shields MatthewEVP, Global Operations | SSale | −16.2K | $32.87 | −$532.3K | −61.9%9.99K after | 10b5-1 |
| Mar 9, 2026 (view filing) | Mar 5 | 4 days | Shields MatthewEVP, Global Operations | SSale | −17.3K | $31.67 | −$547.7K | −63.4%9.99K after | 10b5-1 |
| Jun 5, 2025 (view filing) | Jun 3 | 2 days | Shields MatthewEVP, Global Operations | SSale | −6.21K | $17.02 | −$105.6K | −38.3%9.99K after |